Caribou Biosciences, Inc. - 10-Q Filing

Caribou Biosciences reports third quarter 2026 financial results with significant customer concentration and fair value measurement disclosures.

SEC EDGAR ·

Tickers: $CRBU

Read the full article at SEC EDGAR

More Regulatory news